DE60131545D1 - Verfahren zur behandlung von reaktiver arthritis oder schleimbeutelentzündung - Google Patents

Verfahren zur behandlung von reaktiver arthritis oder schleimbeutelentzündung

Info

Publication number
DE60131545D1
DE60131545D1 DE60131545T DE60131545T DE60131545D1 DE 60131545 D1 DE60131545 D1 DE 60131545D1 DE 60131545 T DE60131545 T DE 60131545T DE 60131545 T DE60131545 T DE 60131545T DE 60131545 D1 DE60131545 D1 DE 60131545D1
Authority
DE
Germany
Prior art keywords
barebell
illumination
reactive arthritis
treating reactive
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60131545T
Other languages
English (en)
Other versions
DE60131545T2 (de
Inventor
Ernest L Bonner
Robert Hines
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ficaar Inc
Original Assignee
Ficaar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ficaar Inc filed Critical Ficaar Inc
Publication of DE60131545D1 publication Critical patent/DE60131545D1/de
Application granted granted Critical
Publication of DE60131545T2 publication Critical patent/DE60131545T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60131545T 2000-07-10 2001-07-10 Verfahren zur behandlung von reaktiver arthritis oder schleimbeutelentzündung Expired - Fee Related DE60131545T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/613,876 US6197776B1 (en) 1999-03-17 2000-07-10 Method for treatment of reactive arthritis or bursitis
US613876 2000-07-10
PCT/US2001/021916 WO2002003920A2 (en) 2000-07-10 2001-07-10 Method for treatment of reactive arthritis or bursitis

Publications (2)

Publication Number Publication Date
DE60131545D1 true DE60131545D1 (de) 2008-01-03
DE60131545T2 DE60131545T2 (de) 2008-09-25

Family

ID=24459020

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60131545T Expired - Fee Related DE60131545T2 (de) 2000-07-10 2001-07-10 Verfahren zur behandlung von reaktiver arthritis oder schleimbeutelentzündung

Country Status (10)

Country Link
US (1) US6197776B1 (de)
EP (1) EP1313464B1 (de)
JP (1) JP2004513073A (de)
CN (1) CN1270704C (de)
AU (2) AU8051901A (de)
CA (1) CA2415774C (de)
DE (1) DE60131545T2 (de)
DK (1) DK1313464T3 (de)
ES (1) ES2296781T3 (de)
WO (1) WO2002003920A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691831B2 (en) * 1999-03-17 2010-04-06 Ernest L. Bonner, Jr. Pharmaceutical combination and method for treatment of reactive arthritis or bursitis
US20050137181A1 (en) * 1999-03-17 2005-06-23 Bonner Ernest L. Method for treatment of reactive arthritis or bursitis
US7884090B2 (en) * 1999-03-17 2011-02-08 Ernest L. Bonner, Jr. Compositions and methods for the treatment of arthritis
US6197776B1 (en) * 1999-03-17 2001-03-06 Ernest L. Bonner, Jr. Method for treatment of reactive arthritis or bursitis
US6765000B2 (en) * 1999-03-17 2004-07-20 Bonner Jr Ernest L Treatment for reactive arthritis or bursitis
US8563525B2 (en) 2004-01-12 2013-10-22 Natrogen Therapeutics International, Inc. Methods of treating an inflammatory-related disease
US20050154046A1 (en) * 2004-01-12 2005-07-14 Longgui Wang Methods of treating an inflammatory-related disease
US7582670B2 (en) * 2001-12-13 2009-09-01 Natrogen Therapeutics, Inc. Methods of treating an inflammatory-related disease
CN1293883C (zh) * 2004-05-21 2007-01-10 邹宏 一种美容修护液及其制备方法
US20060063745A1 (en) * 2004-09-22 2006-03-23 Charles Berman Composition for relieving pain and improving mobility
CA2591157C (en) * 2004-12-17 2012-06-12 Venus Remedies Limited Antibiotic combinations for providing total solution to the treatment of infections
ES2246736B1 (es) * 2005-06-09 2006-12-01 Jose Juan Rodriguez Jerez "composicion farmaceutica que comprende un principio activo antivirico y usos correspondientes".
CN101426268B (zh) * 2007-11-02 2010-08-25 大唐移动通信设备有限公司 导频资源分配方法、系统和设备
WO2022250692A1 (en) * 2021-05-28 2022-12-01 Henderson Theodore Treatment using an antiviral compound and nitazoxanide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946801A (en) * 1957-06-05 1960-07-26 Standard Oil Co Production of pyridine carboxylic acids
US3148212A (en) * 1961-12-22 1964-09-08 American Cyanamid Co Reductive alkylation process
USRE26253E (en) * 1963-05-17 1967-08-15 And z-alkylamino-g-deoxytetracycline
US5523297A (en) * 1993-03-02 1996-06-04 The Research Foundation Of State University Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
GB9425487D0 (en) * 1994-12-16 1995-02-15 Res Inst Osteoarthritis treatment
JPH09136842A (ja) * 1995-11-14 1997-05-27 Shigemasa Sawada 抗慢性関節リウマチ剤
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US6087382A (en) * 1999-03-17 2000-07-11 Bonner, Jr.; Ernest L. Method for treatment of reactive arthritis or bursitis
US6197776B1 (en) * 1999-03-17 2001-03-06 Ernest L. Bonner, Jr. Method for treatment of reactive arthritis or bursitis

Also Published As

Publication number Publication date
ES2296781T3 (es) 2008-05-01
EP1313464B1 (de) 2007-11-21
CA2415774A1 (en) 2002-01-17
JP2004513073A (ja) 2004-04-30
CA2415774C (en) 2010-10-12
US6197776B1 (en) 2001-03-06
AU2001280519B8 (en) 2002-01-21
AU2001280519B2 (en) 2007-01-04
WO2002003920A2 (en) 2002-01-17
AU8051901A (en) 2002-01-21
EP1313464A4 (de) 2005-12-21
AU2001280519B9 (en) 2002-01-21
WO2002003920A8 (en) 2003-02-13
EP1313464A2 (de) 2003-05-28
DK1313464T3 (da) 2008-03-25
DE60131545T2 (de) 2008-09-25
CN1575167A (zh) 2005-02-02
WO2002003920A3 (en) 2002-06-06
CN1270704C (zh) 2006-08-23

Similar Documents

Publication Publication Date Title
DE60120520D1 (de) Verfahren zur behandlung von abwasser
DE60122532D1 (de) Verfahren zur behandlung von mehreren bohrlochintervallen
ATE259245T1 (de) Verfahren zur behandlung von beweggungsstörungen
DE69806970T2 (de) Verfahren zur behandlung von hartgeweben
ATE296915T1 (de) Verfahren zur textilbehandlung
ATE230617T1 (de) Verfahren und methode zur behandlung von abfällen
DE60122839D1 (de) Verfahren zur Behandlung von chromatbelastetem Abwasser
DE60112435D1 (de) Vorrichtung zur behandlung von abfällen
DE60131545D1 (de) Verfahren zur behandlung von reaktiver arthritis oder schleimbeutelentzündung
DE60216514D1 (de) Verfahren zur behandlung von dämpferkondensat
DE69835419D1 (de) Verfahren zur Behandlung von organischem Abwasser
DE50113292D1 (de) Verfahren zur abreicherung von endotoxinen
DE60035326D1 (de) Verfahren zur Behandlung von Abwasser
ATA17552001A (de) Verfahren zur behandlung säurehältiger abwässer
ATE321832T1 (de) Verfahren zur aufbereitung von oliven
DE60019123D1 (de) Verfahren zur behandlung von petroleumsäuren
DE60101333D1 (de) Verfahren zur behandlung von stickstoff- und/oder phosphor- und/oder organischen stoffen- und/oder schwermetalle enhaltendem abwasser
DE69609082D1 (de) Verfahren zur behandlung von abfällen
ATE483848T1 (de) Verfahren zur behandlung von cellulosischen formkörpern
DE69921623D1 (de) Verfahren zur Behandlung von Entwässerungsflüssigkeit
DE60130524D1 (de) Verfahren zur elektrochemischen Behandlung von Artikeln
ATE307871T1 (de) Verfahren zur behandlung von gewebe
DE60016755D1 (de) Verfahren zur behandlung von rohöl
DE60141715D1 (de) Verfahren zur verringerung von harngeruch und gegenstand zur verringerung von harngeruch
DE60119671D1 (de) Verfahren zur Behandlung von Holzwerkstoff

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee